Belief BioMed (BBM) and Takeda China have announced China’s National Medical Products Administration's (NMPA) approval for ...

Lilly is the third company to partner with Sangamo on STAC-BBB after Astellas Gene Therapies, which paid $20 million upfront to kick off a $1.3 billion partnership in December, and Roche, which made ...

"The traditional treatment of hemophilia B requires frequent intravenous injections, and the factor level fluctuates ... This is the first hemophilia B gene therapy drug and the first recombinant ...

Gene therapy is an area of intensive research and development in the retina space, with promising prospects and significant challenges. The benefits and pitfalls of gene therapy were discussed by two ...